The city of Indianapolis, Indiana, currently has 135 active clinical trials seeking participants for Cancer research studies.
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Recruiting
BCDx is a urine-based multi-omic assay for early cancer recurrence detection in patients with a history of bladder cancer. This prospective, blinded study evaluates its efficacy in detecting recurrent NMIBC, offering a noninvasive monitoring solution.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/08/2024
Locations: Indiana University School of Medicine, Indianapolis, Indiana
Conditions: Bladder Cancer
Increasing Equity in Lung Cancer Screening
Recruiting
The overall objective of this mixed methods study is to: 1) Refine the Emergency Department Lung Cancer Screening (ED-LCS) intervention using qualitative interviews among key stakeholders; 2) pilot test the ED-LCS intervention evaluating the intervention efficacy, acceptability, and feasibility; and 3) provide an in-depth description of stakeholders' experiences with the ED-LCS intervention for future refinement.
Gender:
ALL
Ages:
Between 50 years and 80 years
Trial Updated:
04/08/2024
Locations: Eskenazi Health, Indianapolis, Indiana
Conditions: Lung Cancer
Exercise Intervention in Adolescent and Young Adult Cancer Survivors
Recruiting
Adolescent and young adult (AYA) survivors of cancer face a future of persistent medical issues across a wide spectrum of diseases One study examining health data from this cohort (ages 15-29) reported significantly higher rates of smoking, obesity, cardiovascular disease, hypertension, asthma, and poorer mental health among the cancer survivors when compared to healthy controls. Prescribed exercise has broad and far-reaching beneficial physiological effects that cut across multiple body systems... Read More
Gender:
ALL
Ages:
Between 15 years and 39 years
Trial Updated:
11/27/2023
Locations: Riley Hospital for Children - Indiana University, Indianapolis, Indiana +1 locations
Conditions: Long-term Effects Secondary to Cancer Therapy in Adults, Pediatric Cancer